Golden
BioMedPartners

BioMedPartners

A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies

All edits

Edits on 7 Mar 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 7 Mar 2020 9:13 am
Edits made to:
Article (+20/-20 characters)

Article

BioMedPartners is a European private equity and venture capital firmventure capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Edits on 9 Feb 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 9 Feb 2020 2:45 pm
Edits made to:
Article (+14/-14 characters)

Article

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture roundsventure rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Edits on 4 Feb 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 4 Feb 2020 9:30 am
Edits made to:
Article (+7/-7 characters)

Article

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, CuretisCuretis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Edits on 22 Jan 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 22 Jan 2020 12:13 pm
Edits made to:
Article (+5/-5 characters)

Article

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in BaselBasel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 22 Jan 2020 12:08 pm
Edits made to:
Article (+11/-11 characters)

Article

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, SwitzerlandSwitzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Marie Gabrielle Laguna-Bedia
Marie Gabrielle Laguna-Bedia edited on 22 Jan 2020 11:55 am
Edits made to:
Description (+142 characters)
Article (+642 characters)
Topic thumbnail

BioMedPartners

A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies

Article

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.

Edits on 20 Jan 2020
Marie Gabrielle Laguna-Bedia
Marie Gabrielle Laguna-Bedia edited on 20 Jan 2020 4:35 am
Edits made to:
Infobox (+6/--1 properties)
Timeline (+1 events) (+7 characters)
People (+5 rows) (+10 cells) (+166 characters)
Companies (+10 rows) (+10 cells) (+164 characters)

People

Name
Role
LinkedIn

Andreas Wallnöfer

General Partner

Karl Deres

Venture Partner

Patrick Burgermeister

Partner

Stefan Fäs

Chief Financial Officer & Partner

Thomas Möller

General Partner

Companies

Company
CEO
Location
Products/Services

ImmunOs Therapeutics

Alentis Therapeutics

Aleva Neurotherapeutics

Amal Therapeutics

Amal Therapeutics

Camel-IDS

Hookipa Pharma

Miracor Medical

TOLREMO therapeutics

Tricares

Infobox

Location
Company status
Active
Founded date
2017

Timeline

2017

Founded

Edits on 15 Aug 2019
Neelam Jhaveri
Neelam Jhaveri edited on 15 Aug 2019 3:07 am
Edits made to:
Infobox (+2 properties)
Edits on 21 Jun 2019
Golden AI
Golden AI approved a suggestion from Golden's AI on 21 Jun 2019 6:26 pm
Edits made to:
Infobox (+3 properties)
Topic thumbnail

BioMedPartners

A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies

Infobox

Golden AI"Initial topic creation"
Golden AI created this topic on 21 Jun 2019 6:26 pm
Edits made to:
Topic thumbnail

 BioMedPartners

A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies

No more activity to show.